The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Preparation of Messenger RNA Nanomicelles via Non-Cytotoxic PEG-Polyamine Nanocomplex for Intracerebroventicular Delivery: A Proof-of-Concept Study in Mouse Models
Open accessAbstract
The specific delivery of messenger RNA (mRNA) is an excellent alternative to plasmid DNA, due to the latter’s potential risk for random integration into the host genome. In this study, we propose the use of specially tailored polyplex nanomicelles for the intravenous delivery of mRNA into the brain of mice. In brief, along the backbone of a polyaspartamide polymer that is terminated with a 42k Polyethylene glycol chain (PEG), aminoethylene-repeating groups (two, three, and four units, respectively) were conjugated to side-chains to promote electrostatic interactions with mRNA. This structural configuration would ultimately condense into a polyplex nanomicelle ranging between 24 and 34 nm, as was confirmed by transmission electron microscopy (TEM) and dynamic light scattering (DLS) while the chemistry of the synthesis was validated through NMR analysis. Subsequently, we hypothesized an important correlation pertaining to the role of hydrogen bonding between the interaction of polyamine and mRNA in due course. As a proof of concept, we encapsulated the luciferase (Luc2) mRNA as a reporter gene through in vitro transcription (IVT) and subsequently infused the polyplex nanomicelles into mouse brains via an intracerebroventricular (ICV) injection to bypass the blood–brain barriers (BBB). Data revealed that PEGylated polyplex nanomicelles possessing four repeating units of aminoethylene groups had exhibited the best Luc2 mRNA delivery efficiency with no significant immune response registered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, drugs entrapped in micelles are protected from unexpected interactions and biodegradation in vivo environment, resulting in prolongation of the half-life and improved efficiency [49,50,51].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,113
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,725
Synthetic DNA delivery systems
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,625
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 545
In vivo toxicity of cationic micelles and liposomes
Knudsen, K. B., Northeved, H., Ek, P. K., Permin, A., Gjetting, T., Andresen, T. L., Larsen, S., Wegener, K. M., Lykkesfeldt, J., Jantzen, K., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.004 · Cited by 357
Uchida, H., Miyata, K., Oba, M., Ishii, T., Suma, T., Itaka, K., Nishiyama, N., & Kataoka, K. (2011) · Journal of the American Chemical Society · doi:10.1021/ja204466y · Cited by 216
pH-Triggered Reversible “Stealth” Polycationic Micelles
Gu, J., Cheng, W. P., Liu, J., Lo, S.-Y., Smith, D. S., Qu, X., & Yang, Z. (2007) · Biomacromolecules · doi:10.1021/bm701084w · Cited by 211
Cited by
Sorted by citations
Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
van den Berg, A. I. S., Yun, C., Schiffelers, R. M., & Hennink, W. E. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.014 · Cited by 215
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156
The roles of polymers in mRNA delivery
Huang, P., Deng, H., Zhou, Y., & Chen, X. S. (2022) · Matter · doi:10.1016/j.matt.2022.03.006 · Cited by 131
The nano delivery systems and applications of mRNA
Li, M., Li, Y., Li, S., Jia, L., Wang, H., Li, M., Deng, J., Zhu, A., Ma, L., Li, W., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113910 · Cited by 127
Advances in mRNA non-viral delivery approaches
Ibba, M. L., Ciccone, G., Esposito, C. L., Catuogno, S., & Giangrande, P. H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113930 · Cited by 107
Li, X., Qi, J., Wang, J., Hu, W., Zhou, W., Wang, Y., & Li, T. (2024) · Theranostics · doi:10.7150/thno.84291 · Cited by 100
mRNA Cancer Vaccines: Construction and Boosting Strategies
Liu, X., Huang, P., Yang, R., & Deng, H. (2023) · ACS Nano · doi:10.1021/acsnano.3c05635 · Cited by 79
Advances in Nanoparticles for Effective Delivery of RNA Therapeutics
Byun, M. J., Lim, J., Kim, S.-N., Park, D.-H., Kim, T. P., Park, W., & Park, C. G. (2022) · BioChip Journal · doi:10.1007/s13206-022-00052-5 · Cited by 78
Li, L., Zeng, Y., Chen, M., & Liu, G. (2022) · Polymers · doi:10.3390/polym14163278 · Cited by 59
Polymeric-Micelle-Based Delivery Systems for Nucleic Acids
Sinani, G., Durgun, M. E., Cevher, E., & Özsoy, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082021 · Cited by 40
Jarak, I., Pereira‐Silva, M., Paiva‐Santos, A. C., Veiga, F., Cabral, H., & Figueiras, A. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101217 · Cited by 41
Ushering in the era of tRNA medicines
Anastassiadis, T., & Köhrer, C. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105246 · Cited by 38
Rajabi, M., & Feyzbakhsh, H. (2025) · RSC Advances · doi:10.1039/d5ra05399d · Cited by 31
Chang, C.-C., Tsou, H., Chang, H.-H., Chan, L. Y., Zhuo, G., Maeda, T., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010565 · Cited by 27
Self-citationThe main battlefield of mRNA vaccine – Tumor immune microenvironment
Li, X., Ma, S., Gao, T., Mai, Y., Song, Z., & Yang, J. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109367 · Cited by 22
Gu, J., Xu, Z., Liu, Q., Tang, S., Zhang, W., Xie, S., Chen, X., Chen, J., Yong, K., Yang, C., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302409 · Cited by 20
Xiangxun, C., Wu, Y., Dau, V. T., Nguyen, N., & Ta, H. T. (2023) · Biomaterials Science · doi:10.1039/d2bm01594c · Cited by 18
Polyplex nanomicelle delivery of self-amplifying RNA vaccine
Chang, Y., Lin, M., Chien, M.-C., Ke, G., Wu, I.-E., Lin, R.-L., Lin, C., & Hu, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.008 · Cited by 18
Self-citationWang, H., & Cheng, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70002 · Cited by 16
Location of a single histidine within peptide carriers increases mRNA delivery
He, J., Xu, S., Leng, Q., & Mixson, A. J. (2020) · The Journal of Gene Medicine · doi:10.1002/jgm.3295 · Cited by 13
Polymeric Micelles in Targeted Breast Cancer Therapy:Recent Advances and Future Trends
Soni, A., & Jaiswal, V. P. (2025) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2025.9290122 · Cited by 14
Interpolyelectrolyte Complexes as an Emerging Technology for Pharmaceutical Delivery of Polypeptides
Fay, J. M., & Kabanov, A. V. (2022) · Reviews and Advances in Chemistry · doi:10.1134/s2634827622600177 · Cited by 10
Administration of mRNA-Nanomedicine-Augmented Calvarial Defect Healing via Endochondral Ossification
Tsou, H., Wu, C.-H., Chan, L. Y., Kataoka, K., Itokazu, N., Tsuzuki, M., Hu, H., Zhuo, G., Itaka, K., & Lin, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071965 · Cited by 9
Self-citationPolyethylene glycol: structure, properties, and biomedical applications
Sankaranarayanan, S. A., Murugappan, S., Eswar, K., Padmakumar, A., & Rengan, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95233-0.00009-1 · Cited by 8
Vosoughi, P., Naghib, S. M., Rahmanian, M., & Mozafari, M. R. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266325847241121034100 · Cited by 7
Chen, W., Zhu, D., Chen, M., Liu, J., & Liu, X. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70039 · Cited by 4
Miliotou, Α. N., Pappas, I. S., Vizirianakis, I. S., & Papadopoulou, L. C. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_10 · Cited by 3
Polymeric Nanomicelles for Cancer Nanomedicine—Review
Kujundziski, A. P., & Chamovska, D. (2025) · doi:10.3390/engproc2025099012 · Cited by 2
Design strategies to optimize polymeric vectors for mRNA delivery
Turhan, Z. Y., Savaş, M., Alakbarov, A., & Bulmuş, V. (2025) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2025.2587806 · Cited by 2
Tsou, H., Chang, C.-C., Maeda, T., & Lin, C. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_18 · Cited by 2
Self-citationDelivery of mRNA with Histidine-Lysine Peptides
Leng, Q., He, J., Anand, A., & Mixson, A. J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3918-4_23 · Cited by 2
Nanoparticles for Tumor Gene Therapy
Shivhare, R. S., Sabale, V., Ingole, A. R., & Jain, N. (2023) · Wiley eBooks · doi:10.1002/9781394175635.ch6 · Cited by 2
Nanomicelles for the management of COPD
Siddiqui, A., Fairy, Jain, P., Mirza, A., & Iqbal, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43946-9.00012-4
Metadata
- Authors
- Chan, L. Y., Khung, Y. L., & Lin, C.-Y.
- Affiliations
- China Medical University (TW)
- Corresponding author
- Khung, Yit Lung
- Lin, Chin-Yu
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2019-01-05
- Volume
- 9
- Issue
- 1
- Pages
- 67
- ISSN
- 2079-4991 (ISSN-L)
- PMC
- PMC6359661
- OpenAlex
- W2908235105
- Cited by
- 33
- References
- 29
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 5 · 2020: 2
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nanomaterials (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology, Taiwan (107-2314-B-039-023, 107-2622-E-039-003, 107-2113-M-039-002-MY2)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polyaspartamide, intracerebroventricular administration, blood-brain barrier bypass, mRNA delivery, luciferase reporter, hydrogen bonding, immune response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review